Global Emerging Infectious Disease Industry

Global Emerging Infectious Disease Industry Research & Trends Analysis Report

Global Emerging Infectious Disease Industry

Global Emerging Infectious Disease Industry Research & Trends Analysis Report


The Emerging Infectious Disease study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Research by Market IntelliX, the global market for Emerging Infectious Disease should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Emerging Infectious Disease market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Emerging Infectious Disease market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, AIDS segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Clinical Laboratories has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Emerging Infectious Disease include BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex and Gen-Probe, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.

This report aims to provide a comprehensive study of the global market for Emerging Infectious Disease. Report Highlights:

(1) Global Emerging Infectious Disease market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Emerging Infectious Disease market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Emerging Infectious Disease market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Emerging Infectious Disease segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Emerging Infectious Disease segment by type and by application and regional segment by type and by application.

(6) Emerging Infectious Disease industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

AIDS

Ebola

SARS

Avian Flu

Chikungunya

Zika

Others

Market segment by application, can be divided into

Clinical Laboratories

Diagnostic Centers

Others

Market segment by players, this report covers

BD

Abbott

BioMerieux

Danaher

Orasure

Qiagen

Quidel

Sysmex

Gen-Probe

Cepheid

Hologic

1 Market Overview

1.1 Product Overview and Scope of Emerging Infectious Disease

1.2 Global Emerging Infectious Disease Market Size and Forecast

1.3 China Emerging Infectious Disease Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Emerging Infectious Disease Share in Global Market, 2019-2030

1.4.2 Emerging Infectious Disease Market Size: China VS Global, 2019-2030

1.5 Emerging Infectious Disease Market Dynamics

1.5.1 Emerging Infectious Disease Market Drivers

1.5.2 Emerging Infectious Disease Market Restraints

1.5.3 Emerging Infectious Disease Industry Trends

1.5.4 Emerging Infectious Disease Industry Policy

2 Global Competitive Situation by Company

2.1 Global Emerging Infectious Disease Revenue by Company (2019-2024)

2.2 Global Emerging Infectious Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Emerging Infectious Disease Concentration Ratio

2.4 Global Emerging Infectious Disease Mergers & Acquisitions, Expansion Plans

2.5 Global Emerging Infectious Disease Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Emerging Infectious Disease Revenue by Company (2019-2024)

3.2 China Emerging Infectious Disease Emerging Infectious Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Emerging Infectious Disease, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Emerging Infectious Disease Industry Chain

4.2 Emerging Infectious Disease Upstream Analysis

4.3 Emerging Infectious Disease Midstream Analysis

4.4 Emerging Infectious Disease Downstream Analysis

5 Sights by Type

5.1 Emerging Infectious Disease Classification

5.1.1 AIDS

5.1.2 Ebola

5.1.3 SARS

5.1.4 Avian Flu

5.1.5 Chikungunya

5.1.6 Zika

5.1.7 Others

5.2 By Type, Global Emerging Infectious Disease Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Emerging Infectious Disease Revenue, 2019-2030

6 Sights by Application

6.1 Emerging Infectious Disease Segment by Application

6.1.1 Clinical Laboratories

6.1.2 Diagnostic Centers

6.1.3 Others

6.2 By Application, Global Emerging Infectious Disease Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Emerging Infectious Disease Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Emerging Infectious Disease Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Emerging Infectious Disease Market Size, 2019-2030

7.3 North America

7.3.1 North America Emerging Infectious Disease Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Emerging Infectious Disease Market Size Market Share

7.4 Europe

7.4.1 Europe Emerging Infectious Disease Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Emerging Infectious Disease Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Emerging Infectious Disease Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Emerging Infectious Disease Market Size Market Share

7.6 South America

7.6.1 South America Emerging Infectious Disease Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Emerging Infectious Disease Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Emerging Infectious Disease Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Emerging Infectious Disease Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Emerging Infectious Disease Market Size, 2019-2030

8.3.2 By Company, U.S. Emerging Infectious Disease Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.3.4 By Application, U.S. Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.4 Europe

8.4.1 Europe Emerging Infectious Disease Market Size, 2019-2030

8.4.2 By Company, Europe Emerging Infectious Disease Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.4.4 By Application, Europe Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.5 China

8.5.1 China Emerging Infectious Disease Market Size, 2019-2030

8.5.2 By Company, China Emerging Infectious Disease Revenue Market Share, 2019-2024

8.5.3 By Type, China Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.5.4 By Application, China Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.6 Japan

8.6.1 Japan Emerging Infectious Disease Market Size, 2019-2030

8.6.2 By Company, Japan Emerging Infectious Disease Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.6.4 By Application, Japan Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.7 South Korea

8.7.1 South Korea Emerging Infectious Disease Market Size, 2019-2030

8.7.2 By Company, South Korea Emerging Infectious Disease Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.7.4 By Application, South Korea Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Emerging Infectious Disease Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Emerging Infectious Disease Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.8.4 By Application, Southeast Asia Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.9 India

8.9.1 India Emerging Infectious Disease Market Size, 2019-2030

8.9.2 By Company, India Emerging Infectious Disease Revenue Market Share, 2019-2024

8.9.3 By Type, India Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.9.4 By Application, India Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Emerging Infectious Disease Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Emerging Infectious Disease Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

8.10.4 By Application, Middle East & Asia Emerging Infectious Disease Revenue Market Share, 2024 VS 2030

9 Global Manufacturers Profile

9.1 BD

9.1.1 BD Company Information, Head Office, Market Area and Industry Position

9.1.2 BD Company Profile and Main Business

9.1.3 BD Emerging Infectious Disease Models, Specifications and Application

9.1.4 BD Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.1.5 BD Recent Developments

9.2 Abbott

9.2.1 Abbott Company Information, Head Office, Market Area and Industry Position

9.2.2 Abbott Company Profile and Main Business

9.2.3 Abbott Emerging Infectious Disease Models, Specifications and Application

9.2.4 Abbott Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.2.5 Abbott Recent Developments

9.3 BioMerieux

9.3.1 BioMerieux Company Information, Head Office, Market Area and Industry Position

9.3.2 BioMerieux Company Profile and Main Business

9.3.3 BioMerieux Emerging Infectious Disease Models, Specifications and Application

9.3.4 BioMerieux Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.3.5 BioMerieux Recent Developments

9.4 Danaher

9.4.1 Danaher Company Information, Head Office, Market Area and Industry Position

9.4.2 Danaher Company Profile and Main Business

9.4.3 Danaher Emerging Infectious Disease Models, Specifications and Application

9.4.4 Danaher Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.4.5 Danaher Recent Developments

9.5 Orasure

9.5.1 Orasure Company Information, Head Office, Market Area and Industry Position

9.5.2 Orasure Company Profile and Main Business

9.5.3 Orasure Emerging Infectious Disease Models, Specifications and Application

9.5.4 Orasure Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.5.5 Orasure Recent Developments

9.6 Qiagen

9.6.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.6.2 Qiagen Company Profile and Main Business

9.6.3 Qiagen Emerging Infectious Disease Models, Specifications and Application

9.6.4 Qiagen Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.6.5 Qiagen Recent Developments

9.7 Quidel

9.7.1 Quidel Company Information, Head Office, Market Area and Industry Position

9.7.2 Quidel Company Profile and Main Business

9.7.3 Quidel Emerging Infectious Disease Models, Specifications and Application

9.7.4 Quidel Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.7.5 Quidel Recent Developments

9.8 Sysmex

9.8.1 Sysmex Company Information, Head Office, Market Area and Industry Position

9.8.2 Sysmex Company Profile and Main Business

9.8.3 Sysmex Emerging Infectious Disease Models, Specifications and Application

9.8.4 Sysmex Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.8.5 Sysmex Recent Developments

9.9 Gen-Probe

9.9.1 Gen-Probe Company Information, Head Office, Market Area and Industry Position

9.9.2 Gen-Probe Company Profile and Main Business

9.9.3 Gen-Probe Emerging Infectious Disease Models, Specifications and Application

9.9.4 Gen-Probe Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.9.5 Gen-Probe Recent Developments

9.10 Cepheid

9.10.1 Cepheid Company Information, Head Office, Market Area and Industry Position

9.10.2 Cepheid Company Profile and Main Business

9.10.3 Cepheid Emerging Infectious Disease Models, Specifications and Application

9.10.4 Cepheid Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.10.5 Cepheid Recent Developments

9.11 Hologic

9.11.1 Hologic Company Information, Head Office, Market Area and Industry Position

9.11.2 Hologic Company Profile and Main Business

9.11.3 Hologic Emerging Infectious Disease Models, Specifications and Application

9.11.4 Hologic Emerging Infectious Disease Revenue and Gross Margin, 2019-2024

9.11.5 Hologic Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Emerging Infectious Disease Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Emerging Infectious Disease Market trending toward high growth trajectories?
A dynamic process in the Emerging Infectious Disease Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Pfizer, Moderna, Gilead, Merck, Sanofi, AstraZeneca, etc..
What is the Emerging Infectious Disease Market really preparing for?
Companies in the Emerging Infectious Disease Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
Where are the Emerging Infectious Disease used?
The Emerging Infectious Disease are employed in COVID-19, Influenza, Monkeypox, Zoonotic Viruses.
What is the expected rate of growth in the Emerging Infectious Disease Market?
From 2025 to 2030, the Emerging Infectious Disease Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What does the future hold for the Emerging Infectious Disease Market?
As the shift to value addition continues, companies in the Emerging Infectious Disease Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the CAGR at which the Emerging Infectious Disease Market can expand?
During the forecast years, the Emerging Infectious Disease Market can thrive with a robust CAGR.